Peer, Dan

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 8,710

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 2,220

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., et al. (2020) · Science Advances

RNA Interference and Gene DeliveryCRISPR and Genetic Engineering

Cited by 614

The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation

Kedmi, R., Ben-Arie, N., & Peer, D. (2010) · Biomaterials

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 546

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Schlich, M., Palomba, R., Costabile, G., Mizrahy, S., Pannuzzo, M., Peer, D., & Decuzzi, P. (2021) · Bioengineering & Translational Medicine

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 387

A modular platform for targeted RNAi therapeutics

Kedmi, R., Veiga, N., Ramishetti, S., Goldsmith, M., Rosenblum, D., Dammes, N., Hazan-Halevy, I., Nahary, L., Leviatan-Ben-Arye, S., Harlev, M., et al. (2018) · Nature Nanotechnology

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 320

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

Veiga, N., Goldsmith, M., Granot, Y., Rosenblum, D., Dammes, N., Kedmi, R., Ramishetti, S., & Peer, D. (2018) · Nature Communications

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 308

Principles for designing an optimal mRNA lipid nanoparticle vaccine

Kon, E., Elia, U., & Peer, D. (2022) · Current Opinion in Biotechnology

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 269

Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery

Nogueira, S. S., Schlegel, A., Maxeiner, K., Weber, B., Barz, M., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Ramishetti, S., Peer, D., et al. (2020) · ACS Applied Nano Materials

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 252

Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles

Cohen, Z. R., Ramishetti, S., Peshes-Yaloz, N., Goldsmith, M., Wohl, A., Zibly, Z., & Peer, D. (2015) · ACS Nano

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 182

Monoclonal antibody-based molecular imaging strategies and theranostic opportunities

Dammes, N., & Peer, D. (2020) · Theranostics

Radiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and Applications

Cited by 138

Personalized Hydrogels for Engineering Diverse Fully Autologous Tissue Implants

Edri, R., Gal, I., Noor, N., Harel, T., Fleischer, S., Adadi, N., Green, O., Shabat, D., Heller, L., Shapira, A., et al. (2019) · Advanced Materials

Hydrogels: synthesis, properties, applicationsTissue Engineering and Regenerative Medicine

Cited by 128

Precision Nanomedicine in Neurodegenerative Diseases

Goldsmith, M., Abramovitz, L., & Peer, D. (2014) · ACS Nano

Nanoparticle-Based Drug DeliveryBarrier Structure and Function Studies

Cited by 124

Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma

Elbaz, M., Ad-El, N., Chulanova, Y., Brier, D., Goldsmith, M., Bismuth, M., Brosque, A., Sher, D., Gutkin, A., Bar-On, D., et al. (2025) · Journal of Controlled Release

Ultrasound and Hyperthermia ApplicationsRNA Interference and Gene Delivery

Cited by 28